Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Front Bioeng Biotechnol ; 10: 1053653, 2022.
Article in English | MEDLINE | ID: covidwho-2198669

ABSTRACT

Nanomedicine has been extensively studied for its versatility and broad-spectrum applications of theranostics in the research of respiratory disease. However, to the best of our knowledge, a scientometrics study based on the scientific knowledge assay of the overall situation on nanomedicine applied in the research of respiratory disease has not been reported so far, which would be of major importance to relevant researchers. To explore and exhibit the research status and developing trend of nanomedicines deployed in basic or clinical research in respiratory disease, the research ecosystem and exciting subareas were profiled based on the massive data mining and visualization from the relevant works reported from 2006 to 2021. Data were collected from the Web of Science database. Data statistics software and bibliometric analysis software were employed to visualize the research trend and the relationship between respiratory diseases and nanomedicines in each representative direction. The cluster analysis and burst detections indicated that the improvement of drug delivery and vaccine developments are the up-to-date key directions in nanomedicines for respiratory disease research and treatments. Furthermore, we emphatically studied four branch areas in this field including COVID-19, nanotube, respiratory syncytial virus, and mRNA vaccine those are selected for in-depth mining and bibliometric coupling analysis. Research trends signify the future focuses will center on preventing respiratory diseases with mRNA vaccines using nanoparticle-based approaches. We anticipate our study will enable researchers to have the panorama and deep insights in this area, thus inspiriting further exploitations especially the nanobiomaterial-based systems for theranostic applications in respiratory disease treatment.

3.
Acta Agriculturae Jiangxi ; 34(2):160-165, 2022.
Article in Chinese | CAB Abstracts | ID: covidwho-1964892

ABSTRACT

In this study, 650 tissue samples which were collected from 16 pig farms in Hubei Province, were used to detect porcine circovirus (PCV) and Porcine epidemic diarrhea virus (PEDV). The results showed that the positive rates of PCV1, PCV2, PCV3 and PEDV single infection were 1.08%, 4.15%, 2.46% and 6.46%, respectively. In the double infections, PEDV+PCV2 had the highest positive rate of 3.54%, followed by PCV2+PCV3, with a positive rate of 1.54%. In multiple infections, PEDV+PCV2+PCV3 had the highest positive rate of 2.00%. The results indicated that the positive rates of PEDV and PCV were decreased compared with the previous studies, but the prevalence of PEDV and PCV was still wide in Hubei Province, and most of which were co-infection.

4.
Endocrine ; 78(3): 436-440, 2022 12.
Article in English | MEDLINE | ID: covidwho-1956006

ABSTRACT

The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious infectious disease. In addition to typical flu-like symptoms, COVID-19 can also cause extrapulmonary spread and systemic inflammation, potentially causing multiorgan dysfunction, including thyroid dysfunction. Thyroid function changes in patients with COVID-19 have been widely reported, but the results are inconsistent. Based on available data, SARS-CoV-2 infection can lead to changes in thyroid function, and the degree of thyroid function changes was positively correlated with the severity of COVID-19, which involved multiple potential mechanisms. In contrast, current evidence was insufficient to prove that thyroid function changes could induce the progression of COVID-19 clinical deterioration.


Subject(s)
COVID-19 , Animals , SARS-CoV-2 , Chickens , Thyroid Gland , Inflammation
6.
Int J Environ Res Public Health ; 18(6)2021 03 15.
Article in English | MEDLINE | ID: covidwho-1136481

ABSTRACT

Information on coronavirus disease 2019 (COVID-19) has been a significant focus for the global public since the outbreak of the disease. In response, data visualization has become the main form of media used to inform the public about the global pandemic's progress. This paper studies the example of China, the main country affected by the virus in the early stage of the pandemic, to explain the problems regarding the differences in time, knowledge, and technology for information transmission. This paper also tries to explain the causes behind the dissemination of rumors, misjudgment of the public, and the difficulties of perception regarding pandemic information based on the three aspects of information collection, processing, and presentation. We argue that comprehensive information transmission with direct and clear visual presentation could help the public better understand the development of the pandemic, relieve social panic, and help authorities promptly adjust public health policies to absorb the social and economic impacts of the pandemic. Based on a case study, we propose that hierarchical presentation, comprehensive descriptions, and accurate visualizations of pandemic data can effectively improve information transmission, thus providing helpful references for authorities and organizations to improve the effectiveness of pandemic information transmission.


Subject(s)
COVID-19 , Social Media , China/epidemiology , Humans , Pandemics , SARS-CoV-2
7.
Endocrinology ; 162(3)2021 03 01.
Article in English | MEDLINE | ID: covidwho-1067370

ABSTRACT

The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sweeping the world in a very short time. Although much has been learned about the clinical course, prognostic inflammatory markers, and disease complications of COVID-19, the potential interaction between SARS-CoV-2 and the thyroid is poorly understood. In contrast to SARS-CoV-1, limited available evidence indicates there is no pathological evidence of thyroid injury caused by SARS-CoV-2. However, subacute thyroiditis caused by SARS-CoV-2 has been reported for the first time. Thyroid dysfunction is common in patients with COVID-19 infection. By contrast, certain thyroid diseases may have a negative impact on the prevention and control of COVID-19. In addition, some anti-COVID-19 agents may cause thyroid injury or affect its metabolism. COVID-19 and thyroid disease may mutually aggravate the disease burden. Patients with SARS-CoV-2 infection should not ignore the effect on thyroid function, especially when there are obvious related symptoms. In addition, patients with thyroid diseases should follow specific management principles during the epidemic period.


Subject(s)
COVID-19 Drug Treatment , COVID-19 , SARS-CoV-2 , Thyroid Diseases , Thyroid Gland/virology , Adrenal Cortex Hormones/therapeutic use , COVID-19/complications , COVID-19/epidemiology , Comorbidity , Female , Heparin, Low-Molecular-Weight/therapeutic use , Humans , Male , Thyroid Diseases/epidemiology , Thyroid Diseases/physiopathology , Thyroid Diseases/therapy , Thyroid Gland/drug effects , Thyroid Gland/physiopathology , Thyroiditis/virology , Thyrotropin/blood , Triiodothyronine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL